603229.SS
603229.SS
CNE100002XK2
ZHEJIANG AUSUN PHARMACEUTICAL C
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
6.8B EUR
6.43B EUR
8.4B EUR
8.24B EUR
Enterprise Value
6.12B EUR
5.79B EUR
7.74B EUR
7.47B EUR
Valuation Multiples
Trailing P/E
74.45x
148.15x
119.44x
88.68x
Forward P/E
19.5x
--
--
--
Price to Sales
8.73x
10.46x
13.32x
13.1x
Price to Book
2.83x
2.69x
3.55x
3.63x
EV/Revenue
7.86x
9.42x
12.27x
11.88x
EV/EBITDA
41.99x
126.17x
76.88x
60.55x
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-1.56%
-1.59%
-0.58%
-0.27%
ende